| 
ARTICLE
The localization and density of immune cells in
primary tumors of human metastatic colorectal cancer
shows an association with response to chemotherapy
Niels Halama, Sara Michel, Matthias Kloor, Inka Zoernig,
Thora Pommerencke, Magnus von Knebel Doeberitz, Peter
Schirmacher, Jürgen Weitz, Niels Grabe and Dirk
Jäger
Cancer Immunity 9 : 1 (19 February 2009) >Abstract
>Full text
>PDF
ARTICLE
Sequential cancer immunotherapy: targeted activity
of dimeric TNF and IL-8
Stefan Bauer, Nicole Adrian, Uta Siebenborn, Natalie
Fadle, Margarita Plesko, Eliane Fischer, Thomas Wüest,
Frank Stenner, Joachim C. Mertens, Alexander Knuth,
Gerd Ritter, Lloyd J. Old and Christoph Renner
Cancer Immunity 9 : 2 (9 March 2009) >Abstract
>Full text
>PDF
REVIEW
Focus on TILs: Prognostic significance of tumor
infiltrating lymphocytes in human melanoma
Darryl A. Oble, Robert Loewe, Ping Yu and Martin C.
Mihm Jr.
Cancer Immunity 9 : 3 (2 April 2009) >Abstract
>Full text
>PDF
ARTICLE
CD44+ cancer cells express higher levels of the
anti-apoptotic protein Bcl-2 in breast tumours
Zahra Madjd, Ali Zare Mehrjerdi, Ali Mohammad Sharifi,
Saadat Molanaei, Shahriar Zohourian Shahzadi and Mohsen
Asadi-Lari
Cancer Immunity 9 : 4 (23 April 2009) >Abstract
>Full text
>PDF
ARTICLE
Safety and immunogenicity of a human and mouse
gp100 DNA vaccine in a phase I trial of patients with
melanoma
Jianda Yuan, Geoffrey Y. Ku, Humilidad F. Gallardo,
Francesca Orlandi, Gregor Manukian, Teresa S. Rasalan,
Yinyan Xu, Hao Li, Shachi Vyas, Zhenyu Mu, Paul B.
Chapman, Susan E. Krown, Katherine Panageas, Stephanie
L. Terzulli, Lloyd J. Old, Alan N. Houghton and Jedd
D. Wolchok
Cancer Immunity 9 : 5 (5 June 2009) >Abstract
>Full text
>PDF
ARTICLE
Expression and serum immunoreactivity of developmentally
restricted differentiation antigens in epithelial
ovarian cancer
Nana E. Tchabo, Paulette Mhawech-Fauceglia, Otavia
L. Caballero, Jeannine Villella, Amy F. Beck, Anthony
J. Miliotto, Jianqun Liao, Christopher Andrews, Shashikant
Lele, Lloyd J. Old and Kunle Odunsi
Cancer Immunity 9 : 6 (26 August 2009) >Abstract
>Full text
>PDF
COMMENTARY
Soluble MHC-peptide complexes: tools for the monitoring
of T cell responses in clinical trials and basic research
Philippe Guillaume, Danijel Dojcinovic and Immanuel
F. Luescher
Cancer Immunity 9 : 7 (25 September 2009) >Abstract
>Full text
>PDF
ARTICLE
Correlation of high and decreased NY-ESO-1 immunity
to spontaneous regression and subsequent recurrence
in a lung cancer patient
Midori Isobe, Shingo Eikawa, Akiko Uenaka, Yoichi
Nakamura, Tetsuo Kanda, Shigeru Kohno, Kiyotaka Kuzushima
and Eiichi Nakayama
Cancer Immunity 9 : 8 (1 October 2009) >Abstract
>Full text
>PDF
ARTICLE
Real-time PCR analysis of genes encoding tumor
antigens in esophageal tumors and a cancer vaccine
Brian T. Weinert, Kausilia K. Krishnadath, Francesca
Milano, Ayako W. Pedersen, Mogens H. Claesson and
Mai-Britt Zocca
Cancer Immunity 9 : 9 (9 October 2009) >Abstract
>Full text
>PDF
ARTICLE
In vivo major histocompatibility complex
class I (MHCI) expression on MHCIlow tumor
cells is regulated by γδ T and NK cells
during the early steps of tumor growth
Joëlle Riond, Stéphane Rodriguez, Marie-Laure
Nicolau, Talal al Saati and Jean Edouard Gairin
Cancer Immunity 9 : 10 (2 November 2009) >Abstract
>Full text
>PDF
|
